CK2—An Emerging Target for Neurological and Psychiatric Disorders

By Castello Julia   Ragnauth Andre   Friedman Eitan   Rebholz Heike  

Pharmaceuticals, Vol. 10, Iss. 1, 2017-01 ,pp. : 7-7

MDPI

Access to resources Recommend Favorite

Protein Kinase CK2: Intricate Relationships within Regulatory Cellular Networks

By Nuñez de Villavicencio-Diaz Teresa   Rabalski Adam J.   Litchfield David W.  

Pharmaceuticals, Vol. 10, Iss. 1, 2017-03 ,pp. : 27-27

MDPI

Access to resources Recommend Favorite

CK2 in Cancer: Cellular and Biochemical Mechanisms and Potential Therapeutic Target

By Chua Melissa M.J.   Ortega Charina E.   Sheikh Ayesha   Lee Migi   Abdul-Rassoul Hussein   Hartshorn Kevan L.   Dominguez Isabel  

Pharmaceuticals, Vol. 10, Iss. 1, 2017-01 ,pp. : 18-18

MDPI

Access to resources Recommend Favorite

In Search of Small Molecule Inhibitors Targeting the Flexible CK2 Subunit Interface

By Bestgen Benoît   Belaid-Choucair Zakia   Lomberget Thierry   Le Borgne Marc   Filhol Odile   Cochet Claude  

Pharmaceuticals, Vol. 10, Iss. 1, 2017-02 ,pp. : 16-16

MDPI

Access to resources Recommend Favorite

The Link between Protein Kinase CK2 and Atypical Kinase Rio1

By Kubiński Konrad   Masłyk Maciej  

Pharmaceuticals, Vol. 10, Iss. 1, 2017-02 ,pp. : 21-21

MDPI

Access to resources Recommend Favorite